0.36
price down icon5.36%   -0.0204
pre-market  Pre-mercato:  .36  
loading

Nexalin Technology Inc Borsa (NXL) Ultime notizie

pulisher
02:57 AM

MSN Money - MSN

02:57 AM
pulisher
Apr 28, 2026

Nexalin reports sleep quality improvement in insomnia study By Investing.com - Investing.com Australia

Apr 28, 2026
pulisher
Apr 28, 2026

Nexalin reports sleep quality improvement in insomnia study - Investing.com

Apr 28, 2026
pulisher
Apr 28, 2026

After 4 weeks, Nexalin insomnia study showed no sham-group sleep gain - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

Nexalin Technology, Inc. Announces Peer-Reviewed Publication with Neuroimaging Data Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia - marketscreener.com

Apr 28, 2026
pulisher
Apr 26, 2026

Nexalin Technology appoints Justin Fleet as CFO - MSN

Apr 26, 2026
pulisher
Apr 26, 2026

Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow

Apr 26, 2026
pulisher
Apr 25, 2026

Nexalin Technology appoints Justin Van Fleet as CFO - MSN

Apr 25, 2026
pulisher
Apr 24, 2026

Nexalin Technology slides after pricing $5M stock offering - MSN

Apr 24, 2026
pulisher
Apr 23, 2026

Nexalin announces pivotal insomnia trial, targets Q2 enrollment By Investing.com - Investing.com India

Apr 23, 2026
pulisher
Apr 23, 2026

NXL Nexalin Technology Q4 2025 earnings narrowly miss consensus estimates, shares tick higher as investors overlook minor shortfall.Expert Entry Points - Xã Thanh Hà

Apr 23, 2026
pulisher
Apr 23, 2026

Nexalin Advances Pivotal Insomnia Trial for HALO Clarity - The Globe and Mail

Apr 23, 2026
pulisher
Apr 22, 2026

NXL (Nexalin Technology Inc.) reports narrow Q4 2025 EPS miss, shares rise 18 percent on positive investor sentiment.Binary Event - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026
pulisher
Apr 22, 2026

Nexalin (NXL) funds 160-patient pivotal HALO Clarity insomnia trial - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

Nexalin announces pivotal insomnia trial, targets Q2 enrollment - Investing.com

Apr 22, 2026
pulisher
Apr 22, 2026

Nexalin Technology, Inc. to Advance Pivotal Clinical Trial for HALO™ Clarity Device Aimed at Treating Moderate-to-Severe Insomnia - Quiver Quantitative

Apr 22, 2026
pulisher
Apr 22, 2026

Nexalin lines up 160-patient insomnia study to support FDA filing - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment - The Manila Times

Apr 22, 2026
pulisher
Apr 21, 2026

NXL Forecast, Price Target & Analyst Ratings | NEXALIN TECHNOLOGY INC (NASDAQ:NXL) - ChartMill

Apr 21, 2026
pulisher
Apr 20, 2026

Nexalin Technology : Investor Presentation March 2026 - marketscreener.com

Apr 20, 2026
pulisher
Apr 20, 2026

Nexalin Technology (NXL) Stock: Why Growth Investors Chase It (-2.65%) 2026-04-20Hedge Fund Inspired Picks - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026
pulisher
Apr 20, 2026

Is Nexalin Technology (NXL) stock failing at resistance | Nexalin Technology posts 4.8% EPS miss, wider loss vs estimatesStability Report - Newser

Apr 20, 2026
pulisher
Apr 16, 2026

Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China - Sahm

Apr 16, 2026
pulisher
Apr 15, 2026

Nexalin Technology (NXL) Advances Alzheimer's Clinical Strategy - GuruFocus

Apr 15, 2026
pulisher
Apr 15, 2026

Nexalin Technology Advances Global Clinical Strategy for Alzheimer’s Treatment Following Key FDA Meetings - Quiver Quantitative

Apr 15, 2026
pulisher
Apr 15, 2026

After FDA and China meetings, Nexalin reshapes Alzheimer’s study - Stock Titan

Apr 15, 2026
pulisher
Apr 15, 2026

Nexalin Technology Inc: Plans to Submit an Am - Moomoo

Apr 15, 2026
pulisher
Apr 15, 2026

Nexalin Technology, Inc. Advances FDA Alzheimer?S Strategy and Designs FDA Application Amendments and U.S. Clinical Strategy Leveraging Extensive Real-World Neurostimulation Data Sets - marketscreener.com

Apr 15, 2026
pulisher
Apr 15, 2026

Exclusive: Nexalin study flags reduced self-injury in adolescents using brain stimulation device - MSN

Apr 15, 2026
pulisher
Apr 15, 2026

What to Know About Nexalin Technology (NXL) Stock Today (Institutional Demand) 2026-04-15Target Price - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 15, 2026
pulisher
Apr 14, 2026

Nexalin Hosts Live Investor Webinar and Q&A - National Today

Apr 14, 2026
pulisher
Apr 14, 2026

Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21 - The Manila Times

Apr 14, 2026
pulisher
Apr 13, 2026

Macro Review: Whats next for Nexalin Technology Inc Equity Warrant stock2026 Decliners & Fast Gain Stock Trading Tips - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

Targets Report: Why is Nexalin Technology Inc Equity Warrant stock going upQuarterly Profit Summary & Daily Growth Stock Investment Tips - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Hedge Fund Moves: Is Nexalin Technology Inc still a buy after recent gains2026 Retail Activity & Low Drawdown Trading Strategies - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

EXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device - Sahm

Apr 10, 2026
pulisher
Apr 10, 2026

Are investors bearish on Nexalin Technology (NXL) Stock | Price at $0.39, Up 1.32%Community Pattern Alerts - Newser

Apr 10, 2026
pulisher
Apr 09, 2026

Hedge Fund Moves: What analysts say about Nexalin Technology Inc stock2026 Price Swings & Daily Price Action Insights - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Profit Review: Whats next for Nexalin Technology Inc Equity Warrant stock2026 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents - Bitget

Apr 09, 2026
pulisher
Apr 09, 2026

Nexalin Technology, Inc. Reports Significant Reductions in Self-Injury Behaviors and Depressive Symptoms in BMC Psychiatry Publication on DIFS Approach - Quiver Quantitative

Apr 09, 2026
pulisher
Apr 09, 2026

Nexalin teen pilot finds noninvasive brain stimulation cut self-harm - Stock Titan

Apr 09, 2026
pulisher
Apr 08, 2026

Levels Update: Will Nexalin Technology Inc benefit from geopolitical trends2026 EndofYear Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

NXL SEC FilingsNexalin Tech 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

Maxim Group Maintains Nexalin Technology(NXL.US) With Buy Rating, Cuts Target Price to $2 - Moomoo

Apr 08, 2026
ZBH ZBH
$83.01
price up icon 0.41%
STE STE
$212.97
price up icon 0.34%
$59.48
price down icon 0.93%
PHG PHG
$26.45
price up icon 0.80%
$61.04
price up icon 0.07%
EW EW
$82.91
price down icon 0.50%
Capitalizzazione:     |  Volume (24 ore):